Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein Networks02:26

Protein Networks

4.7K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.7K
Protein Networks02:26

Protein Networks

2.9K
2.9K
The Extracellular Matrix01:42

The Extracellular Matrix

91.2K
Overview
91.2K
The Extracellular Matrix01:29

The Extracellular Matrix

13.3K
Overview
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
13.3K
Matrix Proteoglycans and Glycoproteins01:21

Matrix Proteoglycans and Glycoproteins

5.6K
Proteoglycans are extensively glycosylated proteins, commonly found in the extracellular matrix, interwoven with collagen fibers. Hyaline cartilage, the most common type of cartilage in the body, consists of short and dispersed collagen fibers associated with large amounts of proteoglycans. These proteoglycans have long negative charges that attract cations, which in turn attract water molecules. This influx of ions and water molecules swells up the proteoglycan like a water-soaked gel that can...
5.6K
Fibronectins Connect Cells with ECM01:25

Fibronectins Connect Cells with ECM

3.7K
Fibronectin is an adhesive glycoprotein present in the extracellular matrix of embryogenic and adult tissue. These molecules primarily aid in regulating cell motility and attachment. A fibronectin molecule is composed of two identical polypeptide chains attached to each other by a pair of disulfide bonds at the C-terminal.
Both proteoglycans and collagen are attached to fibronectin proteins, which, in turn, are attached to integrin proteins. These integrin proteins interact with transmembrane...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Presenilin-1 Affects Melanoma Cell Behavior in an Amyloid Precursor Protein-Rich, Alzheimer's Disease-like, Microenvironment.

International journal of molecular sciences·2026
Same author

A new trastuzumab-ageritin-based immunotoxin that specifically kills breast cancer cells.

International journal of biological macromolecules·2026
Same author

Achieving Predictable Facial Bone Reconstruction at Immediate Implant Placement Utilizing the Facial Allograft Shield Technique.

Compendium of continuing education in dentistry (Jamesburg, N.J. : 1995)·2026
Same author

Commentary: CVM-1118 (foslinanib), a 2-phenyl-4-quinolone derivative, promotes apoptosis and inhibits vasculogenic mimicry via targeting TRAP1.

Pathology oncology research : POR·2026
Same author

GADD45β inhibits RIPK3-mediated NF-κB activation by interfering with NEMO-RIPK1-RIPK3 interactions.

Cell death discovery·2025
Same author

Correction: Margaryan et al. The Stem Cell Phenotype of Aggressive Breast Cancer Cells. <i>Cancers</i> 2019, <i>11</i>, 340.

Cancers·2025

Related Experiment Video

Updated: Apr 4, 2026

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
06:01

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions

Published on: January 7, 2019

7.8K

Cripto-1: an extracellular protein - connecting the sequestered biological dots.

Malgorzata Klauzinska1, Daniel Bertolette1, Sudhamsh Tippireddy1

  • 1a Tumor Growth Factor Section, Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute , Frederick , MD , USA .

Connective Tissue Research
|September 2, 2015
PubMed
Summary

Cripto-1 (CR-1) is an embryonic protein re-expressed in disease, acting as a co-receptor or ligand to drive cell growth and invasion. Understanding CR-1

Keywords:
AutoantibodiesCripto-1Cripto-1 detectiondrug discoveryinflammation

More Related Videos

Avidity-based Extracellular Interaction Screening AVEXIS for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions
12:30

Avidity-based Extracellular Interaction Screening AVEXIS for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions

Published on: March 5, 2012

22.3K
Analysis of Protein-protein Interactions and Co-localization Between Components of Gap, Tight, and Adherens Junctions in Murine Mammary Glands
11:31

Analysis of Protein-protein Interactions and Co-localization Between Components of Gap, Tight, and Adherens Junctions in Murine Mammary Glands

Published on: May 30, 2017

10.6K

Related Experiment Videos

Last Updated: Apr 4, 2026

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions
06:01

Extracellular Protein Microarray Technology for High Throughput Detection of Low Affinity Receptor-Ligand Interactions

Published on: January 7, 2019

7.8K
Avidity-based Extracellular Interaction Screening AVEXIS for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions
12:30

Avidity-based Extracellular Interaction Screening AVEXIS for the Scalable Detection of Low-affinity Extracellular Receptor-Ligand Interactions

Published on: March 5, 2012

22.3K
Analysis of Protein-protein Interactions and Co-localization Between Components of Gap, Tight, and Adherens Junctions in Murine Mammary Glands
11:31

Analysis of Protein-protein Interactions and Co-localization Between Components of Gap, Tight, and Adherens Junctions in Murine Mammary Glands

Published on: May 30, 2017

10.6K

Area of Science:

  • Cellular and Molecular Biology
  • Developmental Biology
  • Cancer Research

Background:

  • Cripto-1 (CR-1) is a multifunctional embryonic protein.
  • CR-1 is re-expressed during inflammation, wound repair, and malignant transformation.
  • It functions as a tethered co-receptor or a shed ligand, influencing cell physiology.

Purpose of the Study:

  • To review the role of CR-1 as an extracellular protein.
  • To discuss challenges in developing CR-1 quantitation assays.
  • To define mechanistic avenues for CR-1-targeted drug discovery.

Main Methods:

  • Literature review of CR-1's functions and signaling pathways.
  • Analysis of CR-1's involvement in cell growth, migration, invasion, and EMT.
  • Exploration of CR-1 binding partner proteins (BPPs) and their modulatory effects.
  • Discussion of experimental approaches to overcome assay development issues.

Main Results:

  • CR-1 mediates cell growth, migration, invasion, and epithelial-to-mesenchymal transition (EMT).
  • Key signaling pathways include Nodal-dependent (Smad2/3) and Nodal-independent (Src/p44/42/Akt).
  • Binding partner proteins (BPPs) can agonize or antagonize CR-1 bioactivity.

Conclusions:

  • CR-1's dual role as co-receptor/ligand highlights its complex physiological and pathological functions.
  • Developing accurate CR-1 quantitation assays presents challenges.
  • Understanding CR-1 mechanisms offers potential for novel therapeutic strategies in cancer and regenerative medicine.